Skip to content
HomeLatest newsHealth & wellnessA reason to smile: new study looks at gum disease and the potential benefits of flossing
Man flossing

A reason to smile: new study looks at gum disease and the potential benefits of flossing

In time for National Dental Hygiene Month, we’re sharing the findings of a recent report that counters claims that the habit has no health benefits.

Share Article
share to

“Forget you, flossing!”

That was the message many people got after the Associated Press released a report last year that showed a lack of evidence to support the medical benefits of flossing.

But recent research conducted by the Janssen Research & Development Department of Epidemiology and Johnson & Johnson Consumer, Inc. has found that flossing is associated with a lower prevalence of periodontitis.

Researchers found that people who flossed once or more each week were 17% less likely to have gum disease than those who flossed less frequently.

Unspooling the study findings

The study, published in the Journal of Clinical Periodontology, placed participants into three categories: those who flossed or used an interdental brush (a small brush used to clean between your teeth) zero to one time per week, two to four times a week, and five or more times each week.

After researchers adjusted for factors like age, gender and smoking, they found that people who flossed once or more each week were 17% less likely to have gum disease than those who flossed less frequently. They also determined that flossing one or more days a week reduced the risk for periodontitis by 23%, compared to not flossing at all.

Since this was a cross-sectional study—meaning it didn’t track subjects over a long period of time—a direct cause-and-effect relationship between flossing and gum disease could not be proven.

Nevertheless “it provides some assurance that there may be some benefit to flossing,” says the study’s co-author, Mike Lynch, D.M.D., Ph.D., Global Director of Oral Care and Fellow, Global Scientific Engagement, Johnson & Johnson.

So keep at it—your mouth may thank you later.

More from Johnson & Johnson

What to know about We All Belong: 2023 DEI Impact Review

The annual report details how Johnson & Johnson is harnessing the power of diversity, equity and inclusion to provide better care around the world.

Giving the gift of sight

In Kenya, around 1.5 million people—including children—contend with visual impairment or blindness. Sight For Kids, Johnson & Johnson’s global eye-care partnership, is devoted to changing these stats, one vision screening at a time.

Inside the development of a revolutionary treatment for blood cancers

In 2014, a Johnson & Johnson therapy gained approval for the treatment of a type of B-cell malignancy—increasing survival rates and changing the way scientists approach cancer treatment. These 8 milestone moments tell the transformational story.
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.